International Patent: COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING, AS ACTIVE INGREDIENTS, FUSION PROTEIN INCLUDING ANTI-CD73 ANTIBODY AND IL-2 AND CHIMERIC ANTIGEN RECEPTOR-EXPRESSING IMMUNE CELLS

GENEVA, Sept. 18 -- GI INNOVATION, INC. filed a patent application (KR2026/003516) for “COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING, AS ACTIVE INGREDIENTS, FUSION PROTEIN INCLUDING ANTI-CD73 ANTIBODY AND IL-2 AND CHIMERIC ANTIGEN RECEPTOR-EXPRESSING IMMUNE CELLS”. With publication no. WO/2026/187164, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/20

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....